Vicapsys Life Sciences, Inc. (VICP): auditor change — Vicapsys Life Sciences amends 8-K to correct new auditor name to Assurance Dimensions

Vicapsys Life Sciences, Inc.

Dismissed D. Brooks and Associates CPAs as auditor effective May 12, 2023; their reports included a going-concern doubt.
Appointed Assurance Dimensions as new independent registered public accounting firm for fiscal year 2023 audit.
No disagreements or reportable events with former auditor during fiscal years 2021 and 2022.
This amendment solely corrects the name of the new auditor from "Assurance." to "Assurance Dimensions."

item 4.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Vicapsys Life Sciences, Inc. engaged Assurance Dimensions. as its auditor.

Action: engagement
Auditor: Assurance Dimensions.

Exact text from the filing

On May 12, 2023, 2023, the Board appointed Assurance Dimensions. (“Assurance”) as the Company’s independent registered public accounting firm to audit the Company’s consolidated financial statements for the fiscal year ending December 31, 2023.

View on SEC.gov

Auditor Changes SEC 8-K Item 4.01/4.02 confidence 0.9

Vicapsys Life Sciences, Inc. dismissed D. Brooks and Associates CPAs, P.A. as its auditor.

Action: dismissal
Auditor: D. Brooks and Associates CPAs, P.A.

Exact text from the filing

On May 12, 2023, the Board of Directors (the “Board”) of the Vicapsys Life Sciences, Inc. (the “Company”) approved the dismissal of D. Brooks and Associates CPAs, P.A. (“D. Brooks”) as the Company’s independent registered public accounting firm effective May 12, 2023.

View on SEC.gov

Browse all auditor changes →

Vicapsys Life Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-018151

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.